Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications cost effectiveness nusinersen treatment patients infantile onset later onset spinal
… system (CNS) and neurological diseases, CNS and neurologic treatment, and complications and comorbidities of CNS … and longitudinal data sources Decision-analytic models (cost effectiveness, budget impact, Markov) Economic burden of …
2023 Italian Society of Hygiene, Preventive Medicine, and Public Health (SITI) Conference Share on: Thursday, October 12 - Saturday, October 14, 2023 Conference website Research coauthored by RTI Health Solutions experts will be presented at the 2023 …
… and HTA purposes. However, advice that is sought later in product development will also be useful for the …
… Consortium ( MDIC ) that will work with Parkinson’s patients to determine the benefit and risk tradeoffs they are … standard statistical threshold for determining therapeutic effectiveness in clinical trials may be too conservative and … bringing more therapies to more patients faster and more cost-effectively. This project marks the first time MDIC has …
… patterns Utilization and persistence Drug or device safety Effectiveness of treatment or procedure Populations at particular risk …
… Qualitative research (interviews and focus groups) with patients, physicians, and other stakeholder Developing and … results (e.g., scientific conferences, peer-reviewed publications ) …
… on projects to research gastrointestinal (GI) disease, GI treatment, and complications and comorbidities of GI disease. … through postmarketing Decision-analytic models (cost effectiveness, budget impact, Markov) Drug utilization …
… In 2003, the drug received approval from the FDA for the treatment of glucocorticoid-induced osteoporosis in … the US and the five Nordic countries. When the indication later expanded to men and younger adults, a prospective, … for the case-finding study. RTI-HS interviewed patients about any prior use of FORTEO®, other medications …
… from manufacturers. They can ask for data on product effectiveness, safety, and cost-effectiveness to support formulary management, coverage, … manufacturers developing what are expected to be high-cost treatment options in the future (e.g., cell and gene …
… on projects to research respiratory disease, respiratory treatment, and complications and comorbidities of respiratory … and longitudinal data sources Decision-analytic models (cost effectiveness, budget impact) Drug utilization studies …